Some plant secondary metabolites as promising candidates for the treatment of lung cancer and pancreatic cancer
- Authors: Mezhevova I.V.1, Filippova S.Y.1, Chembarova T.V.1, Gnennaya N.V.1, Zlatnik E.Y.1, Novikova I.A.1, Enin Y.S.1, Burov O.N.2
-
Affiliations:
- National medical research centre for Oncology
- Southern Federal University
- Issue: Vol 27, No 9 (2024)
- Pages: 32-40
- Section: Pharmaceutical chemistry
- URL: https://journals.eco-vector.com/1560-9596/article/view/636216
- DOI: https://doi.org/10.29296/25877313-2024-09-05
- ID: 636216
Cite item
Open Access
Access granted
Abstract
Introdution. Cancer is the second leading cause of death in Russia and the world after cardiovascular diseases. Chemotherapy remains the main line of treatment, but tumor cells can become resistant to drugs. Researchers are working on new effective drugs, including secondary metabolites of plants that have antitumor effects through various mechanisms.
The aim of this study was to investigate the cytotoxic properties of three compounds: alkaloid P1, terpenoid P2, and flavonoid V1 against pancreatic cancer cell line AsPC-1 and non-small cell lung cancer H1299.
Material and methods. Secondary metabolites of Petasites hybrydicus (L.) G. Gaertn., B. Mey. & Scherb. and Viscum album L. were extracted using tetrachloroethylene. For identification of the isolated compounds, high-performance liquid chromatography with mass detection and nuclear magnetic resonance method were used. Non-small cell lung cancer cell line H1299 and pancreatic cancer AsPC-1 were grown in RPMI1640 medium (Gibco, USA) supplemented with 10% FBS (HyClone, USA) and 1% glutamine (Biolot, Russia) under standard conditions. Cell sensitivity to the studied compounds was determined by MTT test.
Results. All three compounds demonstrated antitumor activity against the studied cell lines. Compound V1 increased signs of mesenchymal cells morphology and apoptosis, with IC₅₀ values of 234. 24±21. 56 μM (AsPC-1) and 565. 62±84. 31 μM (H1299). Compound P1 promoted multinucleated cell formation in H1299 culture. Half-inhibitory doses for P1 were 652. 54±56. 12 μM (AsPC-1) and 157. 85±48. 62 μM (H1299). Compound P2 induces cell apoptosis and necrosis and probably affects membrane rigidity. The IC₅₀ values for P2 were 802. 34±121. 02 μM (AsPC-1) and 415. 71±75. 05 μM (H1299).
Conclusions. These compounds can be considered promising antitumor agents for lung cancer and pancreatic cancer.
Full Text
About the authors
I. V. Mezhevova
National medical research centre for Oncology
Author for correspondence.
Email: mezhevova88@gmail.com
ORCID iD: 0000-0002-7902-7278
Junior Research Scientist
Russian Federation, 63, 14-line str., Rostov-on-Don, 344037S. Yu. Filippova
National medical research centre for Oncology
Email: svetlana.filippova1982@gmail.com
ORCID iD: 0000-0002-4558-5896
Research Assistant
Russian Federation, 63, 14-line str., Rostov-on-Don, 344037T. V. Chembarova
National medical research centre for Oncology
Email: tanyshamova@mail.ru
ORCID iD: 0000-0002-4555-8556
Junior Research Scientist
Russian Federation, 63, 14-line str., Rostov-on-Don, 344037
N. V. Gnennaya
National medical research centre for Oncology
Email: ngnennaya@inbox.ru
ORCID iD: 0000-0002-3691-3317
Junior Research Scientist
Russian Federation, 63, 14-line str., Rostov-on-Don, 344037E. Yu. Zlatnik
National medical research centre for Oncology
Email: elena-zlatnik@mail.ru
ORCID iD: 0000-0002-1410-122X
Dr. Sc. (Med.), Professor, Leading Research Scientist
Russian Federation, 63, 14-line str., Rostov-on-Don, 344037I. A. Novikova
National medical research centre for Oncology
Email: novikovainna@yahoo.com
ORCID iD: 0000-0002-6496-9641
Dr. Sc. (Med.), Deputy. General Director for Science
Russian Federation, 63, 14-line str., Rostov-on-Don, 344037Y. S. Enin
National medical research centre for Oncology
Email: dendro51@yandex.ru
ORCID iD: 0000-0002-4572-1579
Research Assistant
Russian Federation, 63, 14-line str., Rostov-on-Don, 344037O. N. Burov
Southern Federal University
Email: bboleg@gmail.com
ORCID iD: 0000-0002-7704-033X
Ph. D. (Chem.), Associate Professor
Russian Federation, 105/42, Bolshaya Sadovaya str., Rostov-on-Don, 344006References
- Shakhzadova A. O., Starinsky V. V., Lisichnikova I. V. The state of cancer care for the population of Russia in 2022. Siberian journal of oncology. 2023; 22(5): 5–13. (In Russ). DOI: 10. 21294/1814-4861-2023-22-5-5-13.
- Shin S. A., Moon S. Y., Kim W. Y. et al. Structure-Based Classification and Anti-Cancer Effects of Plant Metabolites. Int J Mol Sci. 2018; 19(9): 2651. DOI: 10. 3390/ijms19092651.
- Lyu X., Song A. L., Bai Y. L. et al. Inhibitory Effects of Petasin on Human Colon Carcinoma Cells Mediated by Inactivation of Akt/mTOR Pathway. Chin. Med. J. (Engl). 2019; 132(IX): 1071–1078. DOI: 10. 1097/CM9. 0000000000000199.
- Guo L., Kang J. S., Kang N. J. et al. S-petasin Induces Apoptosis and Inhibits Cell Migration Through Activation of p53 Pathway Signaling in Melanoma B16F10 Cells and A375 Cells. Arch. Biochem. Biophys. 2020; 692: 108519. DOI: 10. 1016/j. abb. 2020. 108519.
- Abdelfatah S., Böckers M., Asensio M. et al. Isopetasin and S-isopetasin as Novel P-glycoprotein Inhibitors Against Multidrug-resistant Cancer Cells. Phytomedicine. 2021; 86: 153196. DOI: 10. 1016/j. phymed. 2020. 153196.
- Heishima K., Sugito N., Soga T. et al. Petasin Potently Inhibits Mitochondrial Complex I-based Metabolism that Supports Tumor Growth and Metastasis. J. Clin. Invest. 2021; 131(XVII): e139933. DOI: 10. 1172/JCI139933.
- Matsumoto T., Imahori D., Saito Y. et al. Cytotoxic Activities of Sesquiterpenoids from the Aerial Parts of Petasites japonicus Against Cancer Stem Cells. J. Nat. Med. 2020; 74(IV): 689–701. DOI: 10. 1007/s11418-020-01420-x.
- Zhang L., Hong Z., Zhang R. R. et al. Bakkenolide A Inhibits Leukemia by Regulation of HDAC3 and PI3K/Akt-related Signaling Pathways. Biomed. Pharmacother. 2016; 83: 958–966. DOI: 10. 1016/j. biopha. 2016. 07. 049.
- Melo M. N. O., Batista J. V. D. C., Peñaloza E. M. C. et al. A Scoping Review of Genus Viscum: Biological and Chemical Aspects of Alcoholic Extracts. Plants (Basel). 2023; 12(9): 1811. DOI: 10. 3390/plants12091811.
- Zlatnik E. Yu., Enin Ya. S., Burov O. N. et al. Molecular and cellular aspects of the impact of secondary metabolites of Barberry and Butterbur hybrid on the HeLa cell line. Research and practice in medicine. 2023; 10(4): 31–47. (In Russ.). DOI 10. 17709/2410-1893-2023-10-4-3.
- Filippova S. Yu., Shamova T. V., Timofeeva S. V. et al. The influence of some metabolites from plants of the genus Petasites sp. on the motility of tumor cells in vitro. Genes and Cells. 2022; 17(2): 60–63. (In Russ.). DOI 10. 23868/202209009.
- Timofeeva V., Kit O. I., Filippova S. Yu. et al. Some Plant Metabolites from Petasítes sp. and Their Effect on Cancer Cells Motility in vitro. Journal of Clinical Oncology. 2022; 40(S16): 15077. DOI: 10. 1200/JCO. 2022. 40. 16_suppl. e15077.
- Chiryapkin A. S. Zolotykh D. S., Pozdnyakov D. I. Review of the biological activity of flavonoids: quercetin and kaempferol. Juvenis Scientia. 2023; 9(2): 5–20. (In Russ.). DOI: 10. 32415/jscientia_2023_9_2_5-20.
- Kumar P., Nagarajan A., Uchil P. D. Analysis of Cell Viability by the MTT Assay. Cold Spring Harb Protoc. 2018; 2018(6). DOI: 10. 1101/pdb. prot095505.
- Ritz C., Baty F., Streibig J. C. et al. Dose-Response Analysis Using R. PLoS One. 2015; 10(12): e0146021. DOI: 10. 1371/journal. pone. 0146021.
- Kłos P., Chlubek D. Plant-Derived Terpenoids: A Promising Tool in the Fight against Melanoma. Cancers (Basel). 2022; 14(3): 502. DOI: 10. 3390/cancers14030502.
- Efferth T., Oesch F. Repurposing of Plant Alkaloids for Cancer Therapy: Pharmacology and Toxicology. Semin Cancer Biol. 2021; 68: 143–163. DOI: 10. 1016/j. semcancer. 2019. 12. 010.
- Banyal A., Tiwari S., Sharma A. et al. Vinca Alkaloids as a Potential Cancer Therapeutics: Recent Update and Future Challenges. 3 Biotech. 2023; 13(6): 211. DOI: 10. 1007/s13205-023-03636-6.
- Bao J., Huang B., Zou L. et al. Hormetic Effect of Berberine Attenuates the Anticancer Activity of Chemotherapeutic Agents. PLoS One. 2015; 10(9): e0139298. DOI: 10. 1371/journal. pone. 0139298.
- Jodynis-Liebert J., Kujawska M. Biphasic Dose-Response Induced by Phytochemicals: Experimental Evidence. J Clin Med. 20206; 9(3): 718. DOI: 10. 3390/jcm9030718.
- Zheng B., Zheng Y., Zhang N. et al. Rhoifolin from Plumula Nelumbinis exhibits anti-cancer effects in pancreatic cancer via AKT/JNK signaling pathways. Sci Rep. 2022; 12(1): 5654. DOI: 10. 1038/s41598-022-09581-3.
Supplementary files
